SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-18-016920
Filing Date
2018-03-26
Accepted
2018-03-26 17:07:28
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tv489501_f3.htm F-3 575789
2 EXHIBIT 4.4 tv489501_ex4-4.htm EX-4.4 328341
3 EXHIBIT 4.5 tv489501_ex4-5.htm EX-4.5 345563
4 EXHIBIT 5.1 tv489501_ex5-1.htm EX-5.1 30522
5 EXHIBIT 5.2 tv489501_ex5-2.htm EX-5.2 18539
6 EXHIBIT 23.1 tv489501_ex23-1.htm EX-23.1 3488
7 GRAPHIC tv489501_ex5-1logo1.jpg GRAPHIC 30180
8 GRAPHIC tv489501_ex5-1logo2.jpg GRAPHIC 3463
9 GRAPHIC tv489501_ex5-2logo.jpg GRAPHIC 13287
10 GRAPHIC tv489501_logo1.jpg GRAPHIC 12006
11 GRAPHIC tv489501_logo2.jpg GRAPHIC 9524
  Complete submission text file 0001144204-18-016920.txt   1398232
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-223923 | Film No.: 18713428
SIC: 2834 Pharmaceutical Preparations